Schistosomiasis Control Initiative (SCI)

by Imperial College London
Play Video
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)
Schistosomiasis Control Initiative (SCI)

Project Report | Jul 3, 2017
SCI-supported treatment starts in Nigeria

By Demran Ali | Communications Manager

The first round of SCI-supported treatment has started in Nigeria as part of a collaboration between the SCI and Sightsavers. 

The programme will aim to provide 3 million treatments against schistosomiasis and close to 800,000 treatments against soil-transmitted helminth infections for school-age children, in 54 Local Governorate Authorities, across 5 states.  

The implementation of the programme will be supported by the Nigerian Federal Ministry of Health and Sightsavers, with funding from SCI. Addtionally, SCI will provide technical assistance where appropriate.

This is a very exciting project for SCI, as it has been made possible through unrestricted funds acquired through the recommendation of GiveWell, an international charity evaluator. 

SCI’s Programme Manager for Nigeria, Yolisa Nalule, says: “It is a great feeling to be part of the first treatment programme in these states, with an amazing team supporting it. There were no treatments available for these children before this programme and we hope to see positive results in controlling these diseases over time.”

It is anticipated that all treatments will be distributed by the end of August 2017, with a coverage survey to take place soon after, to determine success.

An estimated 28 million people are in need of treatment for schistosomiasis in Nigeria, but only 30% of these individuals are currently being reached. It is hoped that through partnerships such as the one between Sightsavers and SCI, and with the support of donors including USAID, DFID and individuals, the national programme will be able to scale up treatment for NTDs and reach all those affected.

Links:

Share on Twitter Share on Facebook

About Project Reports

Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.

Sign up for updates

Organization Information

Imperial College London

Location: London - United Kingdom
Website:
Facebook: Facebook Page
Alexandra Weldon
Project Leader:
Alexandra Weldon
London , London United Kingdom

Funded Project!

Combined with other sources of funding, this project raised enough money to fund the outlined activities and is no longer accepting donations.
   

Still want to help?

Find another project in Ethiopia or in Physical Health that needs your help.
Find a Project

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Get incredible stories, promotions, and matching offers in your inbox

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.